|1.||Saidova, B M: 1 article (03/2013)|
|2.||Akhmedov, D R: 1 article (03/2013)|
|3.||Saidov, M S: 1 article (03/2013)|
|4.||Monreal, D: 1 article (01/2005)|
|5.||González, D: 1 article (01/2005)|
|6.||Marín, C M: 1 article (01/2005)|
|7.||Garin-Bastuji, B: 1 article (01/2005)|
|8.||Muñoz, P M: 1 article (01/2005)|
|9.||Díaz, R: 1 article (01/2005)|
|10.||Mainar-Jaime, R C: 1 article (01/2005)|
|1.||Brucellosis (Malta Fever)
07/01/2000 - "The objectives of this study were therefore to assess the characteristics of the SDTH test, to select a Brucella strain that will yield a suitable brucellin for use in the field, and to determine whether the use of serological tests in combination with the SDTH test improves the detection of brucellosis. "
01/01/1949 - "Studies in the laboratory diagnosis of brucellosis; a study of the agglutination and brucellergen tests for brucellosis in an asymptomatic population group."
07/01/2000 - "Nevertheless, cattle infected with microorganisms that serologically cross-react with Brucella may test seropositive for brucellosis 4 to 7 weeks after injection of brucellin, depending on the cross-reacting microorganism. "
08/15/1998 - "A brucellin that effectively detected acute and chronic brucellosis in cattle with experimentally induced brucellosis was used as reference brucellin. "
07/01/1997 - "Three experiments were performed in order to assess the diagnostic value of the Brucellin allergic skin test (AST) in a brucellosis false positive serological reactions (FPSR) context. "
01/01/1999 - "Eight-hundred-and-ninety-six cattle belonging to herds officially designated Brucella-free, and 190 cattle belonging to infected herds were tested with the skin delayed-type hypersensitivity (SDTH) test, using brucellin (273) prepared from a mucoid strain of Brucella abortus. "
05/01/1993 - "The vaccinal strategy was based on the outcome of a skin test for hypersensitivity: the PS brucellin test. "
02/01/1989 - "We also observed the allergic reaction of the infected mice to intracutaneous administration of brucellin and found that the C57/BL was more sensitive than BALB/c. "
03/01/1980 - "The brucellin protein fraction, the cutaneous hypersensitivity reagent did not immunize the mouse and did not interfere with the immunization produced by the PG (cell wall PG extracted with SDS) and LPS fractions. "
01/01/1999 - "The efficacy of the skin delayed-type hypersensitivity using a Brucellin prepared from a mucoid strain of Brucella abortus to detect brucellosis."
|3.||Bovine Brucellosis (Bang's Disease)
07/01/1997 - "The Brucellin skin test as a tool to discriminate false positive serological reactions in bovine brucellosis."
06/01/1986 - "Comparison of the brucellin skin test with the lymphocyte transformation test in bovine brucellosis."
03/01/1985 - "A recommendation is made for interpreting the Brucellin skin test for the diagnosis of bovine brucellosis in non-exposed herds."
03/01/1985 - "The diagnostic efficiency of the Brucellin skin test for bovine brucellosis was evaluated using cattle of known history. "
03/01/1985 - "Evaluation of brucellin skin test for bovine brucellosis."
01/01/1988 - "Reactivation of a residual Brucella abortus 19 vaccine infection in mice by a virulent challenge or by injection of brucellin or of Brucella lipopolysaccharide."
04/01/1987 - "Differentiation of Brucella abortus and Yersinia enterocolitica serotype 09 infections in cattle: the use of specific lymphocyte transformation and brucellin skin tests."
02/01/1997 - "Eleven of fourteen Brucella-infected cows whose infections had been detected by the delayed-type hypersensitivity (DTH) test with brucellergen also developed a DTH reaction when purified P39 was used as the trigger. "
04/01/1987 - "These results indicate that standard Brucella serological tests are unreliable in differentiating the two infections in cattle and that both the Lymphocyte transformation and brucellin skin tests could be used to differentiate bovine brucellosis from yersiniosis."
09/01/1994 - "In the cows, the cutaneous lesion was characterized microscopically as severe, acute, serofibrinous vasculitis; dermal lesions at 6, 12, 25, and 48 hours after brucellin injection consisted of endothelial activation and perivascular exudation that led to progressive accumulation of fibrin, monocytes, macrophages, and lymphocytes. "
|3.||Ribosomal Proteins (Ribosomal Protein)